Osimernib

Osimernib

(Osimertinib)

Therapeutic Class:

kinase inhibitors, specifically, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs).

Generic Name:

Osimertinib

Indication:

For:

  • Treatment of specific types of non-small cell lung cancer (NSCLC) that have certain epidermal growth factor receptor (EGFR) gene mutations.

Supplied as:

Tablet:

    • 80mg 30s

Disclaimer:

Please consult your doctor before taking any medicine. To be sold only on prescription.